SHP2 (PTPN11), an allosteric enzyme involved in RAS–mitogen-activated protein kinase (MAPK) activity, is responsible for Noonan syndrome and is commonly detected in juvenile myelomonocytic leukemias, a condition characterized by errors in blood cell development. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.